These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32595220)

  • 1. Performance of CVD risk equations for older patients assessed in general practice: a cohort study.
    Wells S; Pylypchuk R; Mehta S; Kerr A; Selak V; Poppe K; Grey C; Jackson R
    N Z Med J; 2020 Jun; 133(1517):32-55. PubMed ID: 32595220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How do cardiovascular risk prediction equations developed among 30-74 year olds perform in older age groups? A validation study in 125 000 people aged 75-89 years.
    Mehta S; Jackson R; Poppe K; Kerr AJ; Pylypchuk R; Wells S
    J Epidemiol Community Health; 2020 Jun; 74(6):527-533. PubMed ID: 32144211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of alternative cardiovascular risk prediction equations for population health planning: a routine health data linkage study of 1.7 million New Zealanders.
    Mehta S; Jackson R; Pylypchuk R; Poppe K; Wells S; Kerr AJ
    Int J Epidemiol; 2018 Oct; 47(5):1571-1584. PubMed ID: 30010781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of two Framingham cardiovascular risk equations and the Pooled Cohort equations: A nationwide registry analysis.
    Wallisch C; Heinze G; Rinner C; Mundigler G; Winkelmayer WC; Dunkler D
    Int J Cardiol; 2019 May; 283():165-170. PubMed ID: 30429082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing and validating a cardiovascular risk score for patients in the community with prior cardiovascular disease.
    Poppe KK; Doughty RN; Wells S; Gentles D; Hemingway H; Jackson R; Kerr AJ
    Heart; 2017 Jun; 103(12):891-892. PubMed ID: 28232378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of competing mortality risks on predictive performance of the QRISK3 cardiovascular risk prediction tool in older people and those with comorbidity: external validation population cohort study.
    Livingstone S; Morales DR; Donnan PT; Payne K; Thompson AJ; Youn JH; Guthrie B
    Lancet Healthy Longev; 2021 Jun; 2(6):e352-e361. PubMed ID: 34100008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of contemporary cardiovascular risk stratification scores in Brazil: an evaluation in the ELSA-Brasil study.
    Pedroso Camargos A; Barreto S; Brant L; Ribeiro ALP; Dhingra LS; Aminorroaya A; Bittencourt M; Figueiredo RC; Khera R
    Open Heart; 2024 Jun; 11(1):. PubMed ID: 38862252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are competing-risk models superior to standard Cox models for predicting cardiovascular risk in older adults? Analysis of a whole-of-country primary prevention cohort aged ≥65 years.
    Cooper H; Wells S; Mehta S
    Int J Epidemiol; 2022 May; 51(2):604-614. PubMed ID: 34109395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of cardiovascular events in subjects in the second Australian National Blood Pressure study.
    Nelson MR; Ryan P; Tonkin AM; Ramsay E; Willson K; Wing LW; Reid CM;
    Hypertension; 2010 Jul; 56(1):44-8. PubMed ID: 20497992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of cardiovascular risk prediction equations in 76 000 people with known cardiovascular disease.
    Holt A; Batinica B; Liang J; Kerr A; Crengle S; Hudson B; Wells S; Harwood M; Selak V; Mehta S; Grey C; Lamberts M; Jackson R; Poppe KK
    Eur J Prev Cardiol; 2024 Jan; 31(2):218-227. PubMed ID: 37767960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of Framingham cardiovascular risk scores by ethnic groups in New Zealand: PREDICT CVD-10.
    Riddell T; Wells S; Jackson R; Lee AW; Crengle S; Bramley D; Ameratunga S; Pylypchuk R; Broad J; Marshall R; Kerr A
    N Z Med J; 2010 Feb; 123(1309):50-61. PubMed ID: 20186242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A unified national cardiovascular disease (CVD) risk generator is required to address equity in the management of CVD risk in clinical practice in New Zealand.
    Kerr A; Wells S; Moffitt A; Lund M; Kreichbaum J; Harwood M; Jackson R
    N Z Med J; 2019 Aug; 132(1500):89-94. PubMed ID: 31415503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment drop-in in a contemporary cohort used to derive cardiovascular risk prediction equations.
    Liang J; Jackson RT; Pylypchuk R; Choi Y; Chung C; Crengle S; Gao P; Grey C; Harwood M; Holt A; Kerr A; Mehta S; Wells S; Poppe K
    Heart; 2024 Aug; 110(17):1083-1089. PubMed ID: 38960588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating Frailty Into the Pooled Cohort Equations to Predict Cardiovascular Disease Among Persons With HIV.
    Kelly SG; Wu K; Tassiopoulos K; Erlandson KM; Koletar SL; Palella FJ;
    J Acquir Immune Defic Syndr; 2021 Jul; 87(3):971-977. PubMed ID: 33625065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Harwood M; Mehta S; Grey C; Wu BP; Selak V; Drury PL; Chan WC; Orr-Walker B; Murphy R; Mann J; Krebs JD; Zhao J; Jackson R
    Lancet; 2021 Jun; 397(10291):2264-2274. PubMed ID: 34089656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of cardiovascular disease risk among people with severe mental illness: A cohort study.
    Cunningham R; Poppe K; Peterson D; Every-Palmer S; Soosay I; Jackson R
    PLoS One; 2019; 14(9):e0221521. PubMed ID: 31532772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease Risk Prediction in the HIV Outpatient Study.
    Thompson-Paul AM; Lichtenstein KA; Armon C; Palella FJ; Skarbinski J; Chmiel JS; Hart R; Wei SC; Loustalot F; Brooks JT; Buchacz K
    Clin Infect Dis; 2016 Dec; 63(11):1508-1516. PubMed ID: 27613562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Pooled Cohort Equations for Prediction of Cardiovascular Risk in a Contemporary Prospective Cohort.
    Emdin CA; Khera AV; Natarajan P; Klarin D; Baber U; Mehran R; Rader DJ; Fuster V; Kathiresan S
    Am J Cardiol; 2017 Mar; 119(6):881-885. PubMed ID: 28061997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.